Leadership
Program Leaders: Aytekin Oto, MD, Wendy Stock, MD, and Russell Szmulewitz, MD
The Clinical and Experimental Therapeutics Program is a cohesive, integrated program with a long-standing focus on drug development at all phases of clinical testing and a strong pharmacogenomics component. The program fosters interaction between basic and clinical scientists for the development of innovative and effective therapies, including image-based approaches.
Key Research Themes
- Conduct pharmacogenomics studies to identify how an individual’s genetic make-up determines their response to drugs, including chemotherapy
- Identify novel molecular targets for cancer therapy
- Develop innovative cancer clinical trials and new biomarkers to predict or measure therapeutic response
- Translate research findings into clinical application and implement new therapies, tests or tools into cancer patient care
Mark Applebaum, MD
Daniel Arber, MD
Christine Bestvina, MD
Douglas Bishop, PhD
Michael Bishop, MD
Elizabeth Blair, MD
Daniel Catenacci, MD
Chin-Tu Chen, PhD
Steven Chmura, MD, PhD
Susan Cohn, MD
Philip Connell, MD
Benjamin Derman, MD
Ami Desai, MD
James Dignam, PhD
M. Eileen Dolan, PhD
Scott Eggener, MD
Gini Fleming, MD
Robert Grossman, PhD*
Olwen Hahn, MD
Howard Halpern, MD, PhD
Daniel Haraf, MD
Yasmin Hasan, MD
Rex Haydon, MD, PhD
Chuan He, PhD**
Philip Hoffman, MD
Andrzej Jakubowiak, MD, PhD
Chien-Min Kao, PhD
Theodore Karrison, PhD
Xavier Keutgen, MD
Hedy Kindler, MD
Richard Larson, MD
Chih-Yi Liao, MD
Stanley Liauw, MD
Wenbin Lin, PhD
Hongtao Liu, MD, PhD
Jennifer McNeer, MD
John Moroney, MD
Rita Nanda, MD
Peter O’Donnell, MD
Olatoyosi Odenike, MD
Aytekin Oto, MD
Akash Patnaik, MD, PhD
Alexander Pearson, MD, PhD
Mei-Yin Polley, PhD
Louis Portugal, MD
Mitchell Posner, MD
Yonglin Pu, MD, PhD
Mark Ratain, MD
Peter Riedell, MD
Kevin Roggin, MD
Ari Rosenberg, MD
Jeremy Segal, MD, PhD
Ardaman Shergill, MD
Sonali Smith, MD
Walter Stadler, MD
Wendy Stock, MD
Randy Sweis, MD
Russell Szmulewitz, MD
Kiran Turaga, MD
Everett Vokes, MD
Ralph Weichselbaum, MD
S. Diane Yamada, MD
Bakhtiar Yamini, MD
* also a member of the Cancer Prevention and Control Program
** also a member of the Molecular Mechanisms of Cancer Program
Hania Al-Hallaq, PhD
Tatjana Antic, MD
Daniel Appelbaum, MD
Issam Awad, MD
Bulent Aydogan, PhD
Kenneth Bader, PhD
Tessa Balach, MD
David Chang, MD
Nicole Cipriani, MD
Kenneth Cohen, MD
Jessica Donington, MD, MSCR
Oliver Eng, MD
Mark Ferguson, MD
Daniel Golden, MD, MHPE
John Hart, MD
Elizabeth Hyjek, MD
Aditya Juloori, MD
Edwin Kaplan, MD
Katherine Kurnit, MD
Patrick La Riviere, PhD
Gabrielle Lapping-Carr, MD
Mark Levin, PhD
Heber MacMahon, MB, ChB
Susana Marino, MD, PhD
Kathryn Mills, MD
Jeffrey Mueller, DO
Anjana Pillai, MD
Steffen Sammet, MD, PhD
Arieh Shalhav, MD
Jordan Slagowski, PhD
Christina Son, MD
Jennifer Tseng, MD
Chun-Su Yuan, MD, PhD
Nicholas Ankenbruck, PhD
Kirk Cahill, MD
Min Chen, PhD
Frederick Howard, MD
Alec Kacew, BA
Vishesh Kothary, MD
Jason Meier, BS
Perry Morocco, MD
Anand Patel, MD
Divya Sood, MD
Yu Tian, PhD
Cancer Articles
